Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies
Kevin E. Fisher(Emory University), Michael R. Rossi(Sema4 (United States)), Debra Saxe(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center), Geoffrey Smith(Amgen (United States)), Volkan Adsay(Koç University), Gabriel Sica(Emory University), Keith A. Delman(Emory University), Charles E. Hill(Emory University), Karen P. Mann(Emory University), Scott Newman(Guardant (United States)), Thomas M. Schneider(Emory University), David H. Lawson(Emory University), Bassel F. El‐Rayes(University of Alabama at Birmingham), Fadlo R. Khuri(American University of Beirut Medical Center), Serdar Balcı(Emory University), Linsheng Zhang(Emory University), Annie S. Morrison(Emory University), Harold C. Sullivan(Emory University), Suresh S. Ramalingam(Emory University), Jason Wang(Stanford University), Rathi N. Pillai(Emory University), Malania M. Wilson(Centers for Disease Control and Prevention), Anthony A. Gal(Emory University), Ragini R. Kudchadkar
Cited by 69
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k